AU2001266089A1 - Regulation of human prostasin-like serine protease - Google Patents

Regulation of human prostasin-like serine protease

Info

Publication number
AU2001266089A1
AU2001266089A1 AU2001266089A AU6608901A AU2001266089A1 AU 2001266089 A1 AU2001266089 A1 AU 2001266089A1 AU 2001266089 A AU2001266089 A AU 2001266089A AU 6608901 A AU6608901 A AU 6608901A AU 2001266089 A1 AU2001266089 A1 AU 2001266089A1
Authority
AU
Australia
Prior art keywords
regulation
serine protease
human prostasin
prostasin
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001266089A
Other languages
English (en)
Inventor
Vladimir Morozov
Yonghong Xiao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2001266089A1 publication Critical patent/AU2001266089A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
AU2001266089A 2000-06-23 2001-06-22 Regulation of human prostasin-like serine protease Abandoned AU2001266089A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21358800P 2000-06-23 2000-06-23
US60213588 2000-06-23
US27690901P 2001-03-20 2001-03-20
US60276909 2001-03-20
PCT/EP2001/007117 WO2001098467A2 (fr) 2000-06-23 2001-06-22 Regulation de la serine protease humaine de type prostasine

Publications (1)

Publication Number Publication Date
AU2001266089A1 true AU2001266089A1 (en) 2002-01-02

Family

ID=26908219

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001266089A Abandoned AU2001266089A1 (en) 2000-06-23 2001-06-22 Regulation of human prostasin-like serine protease

Country Status (2)

Country Link
AU (1) AU2001266089A1 (fr)
WO (1) WO2001098467A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1297006T3 (da) 2000-06-23 2006-05-22 Bayer Healthcare Ag Regulering af human prostasin-lignende serinprotease
WO2004106536A2 (fr) * 2003-05-28 2004-12-09 Bayer Healthcare Ag Agents diagnostiques et therapeutiques pour maladies associees a la serine protease 8 (prss8)
EP2275547B1 (fr) 2004-12-13 2014-03-05 Alethia Biotherapeutics Inc. Polynucléotides et séquences de polypeptide impliquées dans le procédé de remodelage des os
GB0507577D0 (en) * 2005-04-14 2005-05-18 Novartis Ag Organic compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5500344A (en) * 1992-12-03 1996-03-19 The United States Of America As Represented By The Department Of Health And Human Services Serine protease and uses thereof
WO1999046391A2 (fr) * 1998-03-12 1999-09-16 Millennium Biotherapeutics, Inc. Nouvelles molecules d'acides nucleiques et de proteines pdsp et utilisations correspondantes
EP1396543A3 (fr) * 1999-07-08 2004-03-31 Research Association for Biotechnology Amorces pour la synthèse de cADN de pleine longueur et leur utilisation

Also Published As

Publication number Publication date
WO2001098467A2 (fr) 2001-12-27
WO2001098467A3 (fr) 2002-04-04

Similar Documents

Publication Publication Date Title
AU2002224553A1 (en) Human proteases
AU2001278488A1 (en) Regulation of human matriptase-like serine protease
AU2001281967A1 (en) Regulation of human desc1-like serine protease
AU8573401A (en) Regulation of human epithin-like serine protease
AU5290499A (en) Human htra serine protease
AU2001283872A1 (en) Regulation of human eosinophil serine protease 1-like enzyme
AU2001266089A1 (en) Regulation of human prostasin-like serine protease
AU2001293718A1 (en) Regulation of human membrane-type serine protease
AU2002234568A1 (en) Regulation of human serine palmitoyltransferase
AU2001268967A1 (en) Regulation of human epithin-like serine protease
AU2001269095A1 (en) Regulation of human caspase-1-like protease
AU2001279752A1 (en) Regulation of human masp-like serine protease
AU2002213949A1 (en) Regulation of human serine protease
AU1624501A (en) Human serine protease
AU2001281950A1 (en) Regulation of human thimet oligopeptidase-like enzyme
AU2001256350A1 (en) Regulation of human lysostaphin-like protease
AU2001274080A1 (en) Regulation of human transketolase-like enzyme
AU2002212246A1 (en) Regulation of human serine palmitoyltransferase-like enzyme
AU2003250830A1 (en) Regulation of human subtilase-like serine protease
AU2001238721A1 (en) Human serine protease
AU2002223522A1 (en) Regulation of human pyroglutamyl peptidase-like enzyme
AU2001269097A1 (en) Regulation of human epidermis-specific serine protease
AU2001293846A1 (en) Regulation of a human serine protease
AU2001267548A1 (en) Regulation of human napsin-like aspartyl protease
AU2001258330A1 (en) New uses of imidazolylmethyl-pyridines